NCT00047528View on ClinicalTrials.gov

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Alcon Investigational Agent

Trial Locations (1)

76134

Clinical Trial Sites, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY